Bristol-Myers Squibb Company
BMY
$48.46
$0.561.17%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.62% | 7.32% | 5.56% | 2.93% | -0.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.62% | 7.32% | 5.56% | 2.93% | -0.68% |
| Cost of Revenue | 10.45% | 13.61% | 10.77% | 9.60% | 10.55% |
| Gross Profit | 2.78% | 5.40% | 4.01% | 1.00% | -3.77% |
| SG&A Expenses | -5.71% | 1.86% | 2.02% | 1.37% | 3.15% |
| Depreciation & Amortization | -19.71% | -1.93% | 3.79% | 0.36% | -3.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.86% | 5.69% | 5.32% | 3.24% | 2.69% |
| Operating Income | 33.53% | 14.16% | 6.60% | 1.63% | -13.39% |
| Income Before Tax | 204.48% | -199.28% | -179.77% | -173.81% | -166.46% |
| Income Tax Expenses | 132.18% | 38.50% | 13.98% | -84.86% | -80.30% |
| Earnings from Continuing Operations | 188.62% | -211.11% | -187.28% | -181.84% | -183.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -38.46% | 0.00% | 38.89% | 7.14% | 27.78% |
| Net Income | 188.14% | -211.50% | -187.60% | -182.14% | -184.09% |
| EBIT | 33.53% | 14.16% | 6.60% | 1.63% | -13.39% |
| EBITDA | 3.54% | 5.98% | 5.69% | 1.52% | -7.21% |
| EPS Basic | 186.41% | -214.24% | -190.62% | -186.04% | -189.43% |
| Normalized Basic EPS | 16.22% | -0.55% | 3.17% | 3.48% | -6.00% |
| EPS Diluted | 185.77% | -214.81% | -191.24% | -186.76% | -190.40% |
| Normalized Diluted EPS | 16.19% | -0.27% | 3.59% | 3.96% | -5.57% |
| Average Basic Shares Outstanding | -1.04% | -2.04% | -3.02% | -3.55% | -3.22% |
| Average Diluted Shares Outstanding | -1.03% | -2.31% | -3.42% | -3.98% | -3.66% |
| Dividend Per Share | 4.27% | 4.76% | 5.26% | 5.33% | 5.41% |
| Payout Ratio | 2.17% | -1.92% | -2.16% | -2.24% | -2.22% |